3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Follicular
9
Lymphoma
9
Leukemia, Lymphocytic, Chronic, B-Cell
8
Lymphoma, Mantle-Cell
7
Lymphoma, Non-Hodgkin
6
Lymphoma, Large B-Cell, Diffuse
4
Lymphoma, B-Cell
3
Waldenstrom Macroglobulinemia
2
Recurrence
2
Neoplasms
2
Lymphoma, B-Cell, Marginal Zone
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Neoplasms
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell
1
Leukemia
1
Immunoblastic Lymphadenopathy
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Hematologic Diseases
1
Fallopian Tube Neoplasms
1
Burkitt Lymphoma
1
Interventions
Cyclophosphamide
3
acalabrutinib
2
Rituximab
2
pembrolizumab
1
obinutuzumab
1
ibrutinib
1
fludarabine phosphate
1
fludarabine
1
Whole-Body Irradiation
1
Vincristine
1
Tacrolimus
1
Prednisone
1
Peripheral Blood Stem Cell Transplantation
1
Patient Reported Outcome Measures
1
Mycophenolic Acid
1
Mesna
1
Melphalan
1
Doxorubicin
1
CA-4948
1
Busulfan
1
Bone Marrow Transplantation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphatic Diseases
×
Bendamustine Hydrochloride
×
90 days
×
Clear all
No trials found.